Tech startups use social media avidly [rabidly?], but biotech companies? Not so much. Biotech companies should be blogging, tweeting and linking in like mad, though. Here’s why:
- Your customers (pharma companies) do it. More and more pharma companies are active in social media. Take a look at this article in the December issue of Life Science Leader (h/t @FiercePharma) or read the Dose of Digital blog any day of the week and you’ll be directed to interesting information about how products are being developed, tested and marketed. These are things you need to keep in mind as you move through your own product development process. Also, lots of pharma folks are on LinkedIn, so if you are as well, you’ll maximize your ability to reach out through personal connections when you’re building a constituency for your partnering deals. Here’s my Twitter list of BioPharma news and analysis.
To read the full, original article click on this link: Top Three Reasons why Biotech Companies should use Social Media « The RIC Blog
Author: Jeremy Grushcow
